High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance
Zhe Wu(Shandong University of Traditional Chinese Medicine), Liang Zhou(Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine), Yu Yao(Qinghai University), Ying Mao(Fudan University), Jiang Long Lu(Wenzhou Medical University), Lin Cai(Wenzhou Medical University), Zhen Xiong(Institute of Process Engineering), Shao Jian Lin(Ruijin Hospital)
Cited by 49
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345
Temozolomide-associated hypermutation in gliomas
|Neuro-Oncology|2018|227